The Wall Street Journal reports:
The Food and Drug Administration said Tuesday that the Covid-19 vaccine developed by Moderna is “highly effective,” suggesting the vaccine could soon be added to the arsenal against the pandemic.
Moderna’s documents posted by the FDA included new data suggesting that its vaccine begins to prevent asymptomatic infections after the first dose.
The ability of a vaccine to prevent asymptomatic infections is important because it could help significantly slow the spread of the coronavirus.
BREAKING: An FDA analysis finds Moderna’s #COVID19 vaccine 94.5% effective: 96% for those age 18-64, and 86% for those age 65 or older. FDA advisory meeting vote in a few days and potential emergency authorization later this week. https://t.co/GFBZMkXpJs
— Eric Feigl-Ding (@DrEricDing) December 15, 2020
BREAKING: FDA says Moderna’s Covid vaccine data meets expectations for emergency use https://t.co/b52J6N7tcm
— CNBC Now (@CNBCnow) December 15, 2020